在帕金森病中评估和管理男性性功能障碍:临床路线图
Anessa N Rafetto1, Gillian R Murray1, Matthew J Ziegelmann1
1Department of Urology, Mayo Clinic, Rochester, MN, USA.
Journal of Parkinson's disease
|November 28, 2025
概括
帕金森病 (PD) 可以导致男性的性功能障碍 (SD),影响欲望,兴奋,高潮和亲密性. 早期评估和治疗对于全方位的PD患者护理方法至关重要.
科学领域:
- 神经学 神经学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 性医学性医学性医学性医学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,具有多种运动和非运动症状.
- 性功能障碍 (SD) 是一种常见的,但经常被忽视的,PD患者的表现.
- 皮尔斯顿病影响性功能的多个方面,包括欲望,兴奋,高潮和射精.
研究的目的:
- 为评估和治疗患有帕金森病的男性性功能障碍的当前实践提供概述.
- 突出在PD患者的综合护理中解决SD的重要性.
- 为了强调需要进一步研究女性PD人群中SD的需要.
主要方法:
- 审查美国泌尿病学协会的实践指南,重点关注男性性功能障碍.
- 在PD的背景下分析SD的多因素性质.
- 强调彻底的病史和有针对性的心理性评估.
主要成果:
- 患有PD的患者经常经历性功能的各种障碍.
- 病发症的多因素性质有助于对发展SD的高度脆弱性.
- 目前的指导方针主要针对男性PD人群中的SD.
结论:
- 性功能障碍对患有帕金森病的男性来说是一个重大问题.
- 整体的患者护理需要提高PD中SD的认识和评估.
- 对于女性PD患者存在有限的指导方针,这表明需要未来的研究.
相关概念视频
Disorders of the Male Reproductive System
3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Male Sexual Response: Erection & Ejaculation
17.9K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
17.9K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
534
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
534

